Skip to content

Comparison of the Effects of Glycopyrrolate and Pentamidine Acetate on Postoperative Nausea and Vomiting in Patients Undergoing Painless Gastrointestinal Endoscopy: A Prospective, Randomized, Double-Blind, Positive Parallel-Controlled Clinical Trial

Comparison of the Effects of Glycopyrrolate and Pentamidine Acetate on Postoperative Nausea and Vomiting in Patients Undergoing Painless Gastrointestinal Endoscopy: A Prospective, Randomized, Double-Blind, Positive Parallel-Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097073
Enrollment
Unknown
Registered
2025-02-12
Start date
2025-02-17
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Glonbromide group:The patients will be intravenously given 5 µg / kg of Gronbromide 10 min before the start of the examination.
Penehyclidine hydrochloride group:Patients will be intravenously given penehyclidine hydrochloride 0.01 mg / kg 10 min before the start of the examination.

Sponsors

Henan Provincial Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Age : 18 years <= age < 64 years ; ( 2 ) Body mass index ( BMI ) : 18 kg / m2 <= BMI < 30 kg / m2 ; ( 3 ) American Society of Anesthesiologists ( ASA ) classification : I ~ III ; ( 4 ) Type of surgery : elective painless gastrointestinal endoscopy.

Exclusion criteria

Exclusion criteria: ( 1 ) Glaucoma; ( 2 ) Allergic to glononium bromide, penehyclidine, atropine, scopolamine or other anticholinergic drugs; ( 3 ) acute or chronic nausea or vomiting, or preoperative gastrointestinal motility disorders; ( 4 ) history of schizophrenia, Parkinson 's disease, severe dementia or language disorder; ( 5 ) severe liver dysfunction ( Child-Pugh C ), severe renal dysfunction; ( 6 ) Difficult airways are expected; ( 7 ) Patients involved in other clinical studies.

Design outcomes

Primary

MeasureTime frame
The incidence of PONV;

Secondary

MeasureTime frame
Incidence and severity of PON and POV;The severity of pain;Patient satisfaction with PONV management;The number of cases of postoperative remedial antiemetic drugs;The average time of first anal exhaust after operation;Incidence of postoperative adverse reactions;

Countries

China

Contacts

Public ContactYingchun Guo

Henan Provincial Chest Hospital

zhyjj1985@163.com+86 1872415536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026